Insider Trading Alert - MANH, RPXC And TASR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 26, 2015, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $232.50 to $546,600,000.00.

Highlighted Stocks Traded by Insiders:

Manhattan Associates (MANH) - FREE Research Report

Richards Bruce, who is Sr. V.P. & Chief Legal Officer at Manhattan Associates, sold 1,174 shares at $56.00 on May 26, 2015. Following this transaction, the Sr. V.P. & Chief Legal Officer owned 41,203 shares meaning that the stake was reduced by 2.77% with the 1,174-share transaction.

The shares most recently traded at $54.74, down $1.26, or 2.3% since the insider transaction. Historical insider transactions for Manhattan Associates go as follows:

  • 4-Week # shares sold: 20,000
  • 12-Week # shares sold: 57,852
  • 24-Week # shares sold: 135,359

The average volume for Manhattan Associates has been 416,000 shares per day over the past 30 days. Manhattan Associates has a market cap of $4.1 billion and is part of the technology sector and computer software & services industry. Shares are up 32.88% year-to-date as of the close of trading on Tuesday.

Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. The company has a P/E ratio of 47.9. Currently, there are 2 analysts who rate Manhattan Associates a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MANH - FREE

TheStreet Quant Ratings rates Manhattan Associates as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Manhattan Associates Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

RPX (RPXC) - FREE Research Report

Swank Steven S, who is Senior Vice President at RPX, sold 3,997 shares at $16.06 on May 26, 2015. Following this transaction, the Senior Vice President owned 2,340 shares meaning that the stake was reduced by 63.07% with the 3,997-share transaction.

The shares most recently traded at $15.74, down $0.32, or 2.03% since the insider transaction. Historical insider transactions for RPX go as follows:

  • 4-Week # shares sold: 99,584
  • 12-Week # shares sold: 139,584
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 207,595

The average volume for RPX has been 312,800 shares per day over the past 30 days. RPX has a market cap of $870.5 million and is part of the services sector and diversified services industry. Shares are up 14.15% year-to-date as of the close of trading on Tuesday.

RPX Corporation provides patent risk management solutions in the United States, Japan, and internationally. It offers a subscription-based patent risk management solution that facilitates exchanges of value between owners and users of patents. The company has a P/E ratio of 18.4. Currently, there are 2 analysts who rate RPX a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RPXC - FREE

TheStreet Quant Ratings rates RPX as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, attractive valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full RPX Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Taser International (TASR) - FREE Research Report

Larson Luke, who is President at Taser International, sold 1,035 shares at $33.48 on May 26, 2015. Following this transaction, the President owned 53,059 shares meaning that the stake was reduced by 1.91% with the 1,035-share transaction.

The shares most recently traded at $31.48, down $2.00, or 6.35% since the insider transaction. Historical insider transactions for Taser International go as follows:

  • 4-Week # shares sold: 186,887
  • 12-Week # shares bought: 50,000
  • 12-Week # shares sold: 200,753
  • 24-Week # shares bought: 50,000
  • 24-Week # shares sold: 203,103

The average volume for Taser International has been 2.6 million shares per day over the past 30 days. Taser International has a market cap of $1.7 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 18.2% year-to-date as of the close of trading on Tuesday.

TASER International, Inc. develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. It operates through two segments, TASER Weapons and AXON. The company has a P/E ratio of 72.4. Currently, there are 2 analysts who rate Taser International a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TASR - FREE

TheStreet Quant Ratings rates Taser International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Taser International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Stocks Turn Lower as 10-Year Yield Hits 3%

Stocks Turn Lower as 10-Year Yield Hits 3%

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Tuesday's Market Movers: CAT, UTX, KO, MMM

Tuesday's Market Movers: CAT, UTX, KO, MMM

Wall Street Is Totally Forgetting Apple Will Be Giving Away Tons of Cash in 2018

Wall Street Is Totally Forgetting Apple Will Be Giving Away Tons of Cash in 2018

Vivendi Slides After Reports Vincent Bollore Questioned in Corruption Probe

Vivendi Slides After Reports Vincent Bollore Questioned in Corruption Probe